Japan upgrades PMS (post market surveillance) rules
This article was originally published in Clinica
Executive Summary
New post market surveillance (PMS) guidelines have been drawn up by the Japanese authorities and sent to the prefectural governments for comment. They call for clinical investigations and a review of other published device data and are designed to iron out the deficiencies in the current surveillance system.